加载中
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
前收盘价
US$27.10
−US$0.355 · -1.29%
盘前
US$26.91
−US$0.19 · -0.70%
10月8日 4:01 ET
盘中时间采用ET。市场数据可能有所延迟。
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
日内区间
当前US$27.10
52周区间
当前US$27.10
盘中时间采用ET。市场数据可能有所延迟。
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
日内区间
当前US$27.10
52周区间
当前US$27.10
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2020财年 |
|---|---|---|---|---|---|
| 营收 | 8.12亿 USD | 4.12亿 USD | 3.06亿 USD | 2.58亿 USD | 2.94亿 USD |
| 销货成本 | 2.73亿 USD | 2.33亿 USD | 2.17亿 USD | 1.78亿 USD | 1.1亿 USD |
| 毛利 | 5.39亿 USD | 1.79亿 USD | 8931万 USD | 8002.2万 USD | 1.84亿 USD |
| 研究与开发 | 4531.4万 USD | 1.14亿 USD | 1.17亿 USD | 1.01亿 USD | — |
| 销售、一般及管理费用 | 3.92亿 USD | 3.22亿 USD | 2.91亿 USD | 2.95亿 USD | 2731.2万 USD |
| 营业费用 | 4.94亿 USD | 4.36亿 USD | 4.09亿 USD | 3.96亿 USD | 4507万 USD |
| 利息收入 | 1649.7万 USD | 712.2万 USD | 1125.8万 USD | 94.7万 USD | — |
| 利息支出 | 5685.3万 USD | 5002.5万 USD | 3161万 USD | 2668万 USD | 6156.5万 USD |
| 折旧和摊销 | 2261.5万 USD | 4891.3万 USD | 4900.1万 USD | 4825.3万 USD | 1.11亿 USD |
| 营业利润 | 4511.3万 USD | −2.57亿 USD | −3.2亿 USD | −3.16亿 USD | 1.39亿 USD |
| 净利润 | −5.38亿 USD | −2.82亿 USD | −3.41亿 USD | −3.21亿 USD | 2773.3万 USD |
公司数据更新于 2026年10月8日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI1.03亿0.00%2.3万亿 USD0.03%US$381.03-0.40%
Vanguard Morningstar Small-Cap ETFVB7457.03万0.04%1853亿 USD0.03%US$286.98-1.41%
Vanguard Morningstar Small-Cap Growth ETFVBK4293.1万0.09%447亿 USD0.05%US$342.24-1.50%
iShares Biotechnology ETFIBB2638.18万0.25%104.01亿 USD0.44%US$203.34+0.12%
First Trust Health Care AlphaDEX FundFXH2423.74万2.16%11.31亿 USD0.61%US$128.8-0.32%
Schwab U.S. Small-Cap ETFSCHA1813.08万0.08%220.14亿 USD0.03%US$32.61-1.47%
iShares Russell Mid-Cap Growth ETFIWP1712.32万0.08%201.36亿 USD0.23%US$141.46-1.38%
iShares Russell Mid-Cap ETFIWR1414.22万0.02%565.66亿 USD0.18%US$108.47-1.10%Vanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Growth ETFVBKiShares Biotechnology ETFIBBFirst Trust Health Care AlphaDEX FundFXHSchwab U.S. Small-Cap ETFSCHAiShares Russell Mid-Cap Growth ETFIWPiShares Russell Mid-Cap ETFIWRAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
